Clinical trial

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

NCT03387423

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-11-02

PhaseN/A

Study timeline

Study start (actual)2017-11-02Date precision: day

Registry last updated2024-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritis, Rheumatoidunresolved

Interventions

TofacitinibDRUG · verified · RxNorm: tofacitinib

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

BerlinGermany8 HamburgGermany2 DresdenGermany2 LeipzigGermany2 MünchenGermany1 HanoverGermany1 HeidelbergGermany1 CologneGermany1 MünsterGermany1 UlmGermany1 TübingenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03387423 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.